Also trades as: BANB.SW (SIX) · $vol 12M · 0QND.L (LSE) · $vol 3M

$91.00

+0.00 (+0.00%)

OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 60 · $6.8B mcap · 31M float · 0.0021% daily turnover · Short 100% of daily vol

Revenue

$695M +14.9% ▲

5Y CAGR: +11.6%

Gross Profit

$200M +9.5% ▲

5Y CAGR: +9.2%

Operating Income

$150M +13.0% ▲

5Y CAGR: +9.2%

Net Income

$149M +23.8% ▲

5Y CAGR: +13.8%

EPS (Diluted)

$1.98 +23.7% ▲

5Y CAGR: +12.1%

EBITDA

$190M +6.4% ▲

5Y CAGR: +10.1%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$503M	$532M	$577M	$605M	$695M
YoY Growth	+25.2%	+5.7%	+8.6%	+4.8%	+14.9%
Cost of Revenue	$337M	$360M	$400M	$423M	$496M
Gross Profit	$167M	$171M	$177M	$183M	$200M
Gross Margin	33.1%	32.2%	30.7%	30.2%	28.7%
R&D Expenses	$4M	$7M	$11M	$11M	$10M
SG&A Expenses	$35M	$38M	$37M	$39M	$39M
Operating Expenses	$38M	$44M	$48M	$50M	$49M
Operating Income	$129M	$127M	$129M	$133M	$150M
Operating Margin	25.6%	23.9%	22.4%	22.0%	21.6%
Interest Expense	$365K	$74K	$367K	$50K	$484K
Income Before Tax	$131M	$112M	$124M	$135M	$156M
Tax Expense	$17M	$11M	$12M	$15M	$8M
Net Income	$115M	$101M	$112M	$120M	$149M
Net Margin	22.8%	18.9%	19.4%	19.9%	21.4%
EPS (Diluted)	$1.62	$1.37	$1.50	$1.60	$1.98
EBITDA	$160M	$145M	$158M	$179M	$190M
Shares Outstanding	71M	74M	75M	75M	75M

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$297M	$240M	$337M	$240M	$365M	$313M	$382M	$325M
Cost of Revenue	$196M	$181M	$219M	$179M	$243M	$223M	$273M	$243M
Gross Profit	$100M	$59M	$118M	$61M	$122M	$90M	$110M	$81M
Gross Margin	33.9%	24.4%	35.1%	25.4%	33.3%	28.8%	28.7%	25.0%
R&D Expenses	$5M	$5M	$6M	$7M	$4M	$5M	$5M	$7M
SG&A Expenses	$20M	$19M	$19M	$19M	$20M	$19M	$20M	$21M
Operating Expenses	$29M	$24M	$23M	$26M	$24M	$23M	$26M	$28M
Operating Income	$76M	$34M	$95M	$35M	$98M	$67M	$84M	$53M
Operating Margin	25.5%	14.3%	28.0%	14.7%	26.8%	21.4%	22.0%	16.4%
Interest Expense	$0	$218K	$298K	$0	$50K	$0	$309K	$925K
Income Before Tax	$72M	$37M	$87M	$41M	$95M	$56M	$100M	$56M
Tax Expense	$8M	$2M	$10M	$4M	$11M	$6M	$2M	$6M
Net Income	$64M	$34M	$77M	$36M	$84M	$50M	$99M	$50M
Net Margin	21.6%	14.4%	22.9%	15.0%	23.0%	16.0%	25.8%	15.4%
EPS (Diluted)	$0.86	$0.46	$1.04	$0.48	$1.12	$0.67	$1.32	$0.67
EBITDA	$90M	$55M	$111M	$55M	$123M	$83M	$107M	$82M
Shares Outstanding	74M	75M	74M	75M	75M	75M	75M	75M

BCHMF OTC